North Central Cancer Treatment Group-Achievements and Perspectives

Axel F Grothey, Alex Adjei, Steven Robert Alberts, Edith A. Perez, Kurt A. Jaeckle, Charles Lawrence Loprinzi, Daniel J. Sargent, Jeff A Sloan, Jan Craig Buckner

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The North Central Cancer Treatment Group (NCCTG) was founded in 1977 as a regional cooperative group to allow cancer patients in the upper Midwest of the United States to gain access to clinical trials in oncology by establishing a network of community oncology practices with one academic research base, the Mayo Clinic. Since then, the NCCTG has grown into an international cooperative group with 43 members in 33 US states and Canada. This article details 30 years of achievements of the NCCTG, including important scientific contributions from disease-specific and treatment modality committees, the cancer control program, patient-reported outcomes and quality-of-life research, and biostatisticians that support the NCCTG's specific aims: to improve the duration and quality of life of cancer patients, to enhance our understanding of the biological consequences of cancer and its treatment, and to improve methods for clinical trial conduct.

Original languageEnglish (US)
Pages (from-to)530-544
Number of pages15
JournalSeminars in Oncology
Volume35
Issue number5
DOIs
StatePublished - Oct 2008

Fingerprint

Neoplasms
Therapeutics
Quality of Life
Clinical Trials
Research
Canada

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

North Central Cancer Treatment Group-Achievements and Perspectives. / Grothey, Axel F; Adjei, Alex; Alberts, Steven Robert; Perez, Edith A.; Jaeckle, Kurt A.; Loprinzi, Charles Lawrence; Sargent, Daniel J.; Sloan, Jeff A; Buckner, Jan Craig.

In: Seminars in Oncology, Vol. 35, No. 5, 10.2008, p. 530-544.

Research output: Contribution to journalArticle

@article{d47729f4da1e43ab8034a7833b487ed3,
title = "North Central Cancer Treatment Group-Achievements and Perspectives",
abstract = "The North Central Cancer Treatment Group (NCCTG) was founded in 1977 as a regional cooperative group to allow cancer patients in the upper Midwest of the United States to gain access to clinical trials in oncology by establishing a network of community oncology practices with one academic research base, the Mayo Clinic. Since then, the NCCTG has grown into an international cooperative group with 43 members in 33 US states and Canada. This article details 30 years of achievements of the NCCTG, including important scientific contributions from disease-specific and treatment modality committees, the cancer control program, patient-reported outcomes and quality-of-life research, and biostatisticians that support the NCCTG's specific aims: to improve the duration and quality of life of cancer patients, to enhance our understanding of the biological consequences of cancer and its treatment, and to improve methods for clinical trial conduct.",
author = "Grothey, {Axel F} and Alex Adjei and Alberts, {Steven Robert} and Perez, {Edith A.} and Jaeckle, {Kurt A.} and Loprinzi, {Charles Lawrence} and Sargent, {Daniel J.} and Sloan, {Jeff A} and Buckner, {Jan Craig}",
year = "2008",
month = "10",
doi = "10.1053/j.seminoncol.2008.07.006",
language = "English (US)",
volume = "35",
pages = "530--544",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - North Central Cancer Treatment Group-Achievements and Perspectives

AU - Grothey, Axel F

AU - Adjei, Alex

AU - Alberts, Steven Robert

AU - Perez, Edith A.

AU - Jaeckle, Kurt A.

AU - Loprinzi, Charles Lawrence

AU - Sargent, Daniel J.

AU - Sloan, Jeff A

AU - Buckner, Jan Craig

PY - 2008/10

Y1 - 2008/10

N2 - The North Central Cancer Treatment Group (NCCTG) was founded in 1977 as a regional cooperative group to allow cancer patients in the upper Midwest of the United States to gain access to clinical trials in oncology by establishing a network of community oncology practices with one academic research base, the Mayo Clinic. Since then, the NCCTG has grown into an international cooperative group with 43 members in 33 US states and Canada. This article details 30 years of achievements of the NCCTG, including important scientific contributions from disease-specific and treatment modality committees, the cancer control program, patient-reported outcomes and quality-of-life research, and biostatisticians that support the NCCTG's specific aims: to improve the duration and quality of life of cancer patients, to enhance our understanding of the biological consequences of cancer and its treatment, and to improve methods for clinical trial conduct.

AB - The North Central Cancer Treatment Group (NCCTG) was founded in 1977 as a regional cooperative group to allow cancer patients in the upper Midwest of the United States to gain access to clinical trials in oncology by establishing a network of community oncology practices with one academic research base, the Mayo Clinic. Since then, the NCCTG has grown into an international cooperative group with 43 members in 33 US states and Canada. This article details 30 years of achievements of the NCCTG, including important scientific contributions from disease-specific and treatment modality committees, the cancer control program, patient-reported outcomes and quality-of-life research, and biostatisticians that support the NCCTG's specific aims: to improve the duration and quality of life of cancer patients, to enhance our understanding of the biological consequences of cancer and its treatment, and to improve methods for clinical trial conduct.

UR - http://www.scopus.com/inward/record.url?scp=52949147069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949147069&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2008.07.006

DO - 10.1053/j.seminoncol.2008.07.006

M3 - Article

C2 - 18929151

AN - SCOPUS:52949147069

VL - 35

SP - 530

EP - 544

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 5

ER -